Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

PURPOSE: Salvage second-line chemotherapy is usually recommended for patients with advanced epithelial ovarian cancer (AEOC) who develop progressive disease (PD) after neoadjuvant chemotherapy (NAC). Herein, we investigated the role of cytoreductive surgery (CRS) for such patients. MATERIALS AND MET...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Yonsei Med J
Päätekijät: Shin, Wonkyo, Noh, Joseph J., Seo, Sang-Soo, Kang, Sokbom, Choi, Chel-Hun, Park, Sang-Yoon, Kim, Byoung-Gie, Lim, Myong Cheol
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Yonsei University College of Medicine 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7593099/
https://ncbi.nlm.nih.gov/pubmed/33107236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.11.935
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia